-
Tytuł:
-
Molecular Imaging of Human Skeletal Myoblasts (huSKM) in Mouse Post-Infarction Myocardium.
-
Autorzy:
-
Fiedorowicz K; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Wargocka-Matuszewska W; Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, 02-089 Warsaw, Poland.
Ambrożkiewicz KA; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Rugowska A; Faculty of Biology, Institute of Human Biology and Evolution, Adam Mickiewicz University, 60-479 Poznan, Poland.
Cheda Ł; Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, 02-089 Warsaw, Poland.
Fiedorowicz M; Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.
Zimna A; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Drabik M; Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.
Borkowski S; Institute of Radioelectronics and Multimedia Technology, Warsaw University of Technology, 00-665 Warsaw, Poland.
Świątkiewicz M; Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.
Bogorodzki P; Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.; Institute of Radioelectronics and Multimedia Technology, Warsaw University of Technology, 00-665 Warsaw, Poland.
Grieb P; Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.
Hamankiewicz P; Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, 02-089 Warsaw, Poland.
Kolanowski TJ; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Rozwadowska N; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Kozłowska U; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.; Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.
Klimczak A; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Kolasiński J; Kolasiński Clinic, Hair Clinic Poznan, 62-020 Swarzędz, Poland.
Rogulski Z; Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, 02-089 Warsaw, Poland.
Kurpisz M; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
-
Źródło:
-
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 08; Vol. 22 (19). Date of Electronic Publication: 2021 Oct 08.
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Basel, Switzerland : MDPI, [2000-
-
MeSH Terms:
-
Mesenchymal Stem Cells/*cytology
Molecular Imaging/*methods
Myoblasts, Skeletal/*cytology
Myocardial Infarction/*pathology
Myocardium/*pathology
Animals ; Disease Models, Animal ; Genes, Reporter ; Humans ; Mesenchymal Stem Cells/metabolism ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Myoblasts, Skeletal/metabolism ; Myocardial Infarction/metabolism ; Myocardium/metabolism
-
References:
-
Sci Rep. 2020 Mar 25;10(1):5379. (PMID: 32214151)
Circulation. 2002 Jan 1;105(1):93-8. (PMID: 11772882)
Exp Mol Med. 2013 Nov 15;45:e54. (PMID: 24232253)
Stem Cells Transl Med. 2018 Jul;7(7):543-550. (PMID: 29665255)
J Geriatr Cardiol. 2013 Jun;10(2):186-97. (PMID: 23888179)
J Surg Res. 2007 Oct;142(2):263-7. (PMID: 17719065)
Eur J Heart Fail. 2017 Jan;19(1):148-157. (PMID: 28052545)
Cell Stem Cell. 2013 Jun 6;12(6):689-98. (PMID: 23746978)
Circulation. 2001 Sep 18;104(12 Suppl 1):I207-12. (PMID: 11568057)
Eur J Heart Fail. 2019 Aug;21(8):1032-1041. (PMID: 30790396)
Circulation. 2008 Mar 4;117(9):1189-200. (PMID: 18285565)
J Cell Sci. 2016 Aug 1;129(15):2887-96. (PMID: 27505427)
Sci Rep. 2020 Feb 5;10(1):1895. (PMID: 32024875)
J Am Heart Assoc. 2019 Jun 18;8(12):e012673. (PMID: 31185774)
Cardiovasc Res. 2006 Feb 1;69(2):348-58. (PMID: 16376327)
J Thorac Cardiovasc Surg. 2001 Oct;122(4):759-66. (PMID: 11581610)
J Cell Physiol. 1996 Mar;166(3):585-92. (PMID: 8600162)
Rev Esp Cardiol (Engl Ed). 2015 Jul;68(7):599-611. (PMID: 26028258)
Oncotarget. 2017 May 27;8(40):68780-68794. (PMID: 28978156)
Int J Mol Sci. 2021 Apr 23;22(9):. (PMID: 33922534)
Eur Heart J. 2010 Apr;31(8):1013-21. (PMID: 19700775)
Int J Cardiol. 2016 Jan 1;202:710-21. (PMID: 26457413)
J Heart Lung Transplant. 2005 Nov;24(11):1940-9. (PMID: 16297802)
BMC Cardiovasc Disord. 2006 Jun 06;6:25. (PMID: 16756651)
Circ Res. 2005 Jul 22;97(2):159-67. (PMID: 15976318)
Circulation. 2004 Mar 30;109(12):1543-9. (PMID: 15023891)
Arch Immunol Ther Exp (Warsz). 2018 Apr;66(2):145-159. (PMID: 28951939)
Eur Heart J. 2003 Nov;24(22):2012-20. (PMID: 14613737)
World J Stem Cells. 2019 Jun 26;11(6):347-374. (PMID: 31293717)
Sci Rep. 2017 Mar 15;7:44376. (PMID: 28295048)
Stem Cell Res Ther. 2020 Feb 21;11(1):73. (PMID: 32085809)
Bull Exp Biol Med. 2018 Mar;164(4):536-542. (PMID: 29504093)
-
Grant Information:
-
PBS3/A7/27/2015 Narodowe Centrum Badań i Rozwoju
-
Contributed Indexing:
-
Keywords: Bioluminescent Imaging; Magnetic Resonance Imaging; Single-Photon Emission Computed Tomography/Computed Tomography; human skeletal myoblasts; mesenchymal stem cells; promoter reporter gene; technetium
-
Entry Date(s):
-
Date Created: 20211013 Date Completed: 20211101 Latest Revision: 20211101
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC8509689
-
DOI:
-
10.3390/ijms221910885
-
PMID:
-
34639225
-
Current treatment protocols for myocardial infarction improve the outcome of disease to some extent but do not provide the clue for full regeneration of the heart tissues. An increasing body of evidence has shown that transplantation of cells may lead to some organ recovery. However, the optimal stem cell population has not been yet identified. We would like to propose a novel pro-regenerative treatment for post-infarction heart based on the combination of human skeletal myoblasts (huSkM) and mesenchymal stem cells (MSCs). huSkM native or overexpressing gene coding for Cx43 (huSKMCx43) alone or combined with MSCs were delivered in four cellular therapeutic variants into the healthy and post-infarction heart of mice while using molecular reporter probes. Single-Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) performed right after cell delivery and 24 h later revealed a trend towards an increase in the isotopic uptake in the post-infarction group of animals treated by a combination of huSkMCx43 with MSC. Bioluminescent imaging (BLI) showed the highest increase in firefly luciferase (fluc) signal intensity in post-infarction heart treated with combination of huSkM and MSCs vs. huSkM alone ( p < 0.0001). In healthy myocardium, however, nanoluciferase signal (nanoluc) intensity varied markedly between animals treated with stem cell populations either alone or in combinations with the tendency to be simply decreased. Therefore, our observations seem to show that MSCs supported viability, engraftment, and even proliferation of huSkM in the post-infarction heart.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
